Sorrento Therapeutics Inc (SRNE): Dr. Ji said in an interview that the Abi...

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: Scotttrader80 post# 4702

Tuesday, 07/21/2020 1:59:10 PM

Tuesday, July 21, 2020 1:59:10 PM

Dr. Ji said in an interview that the Abivirtinib phase two trial will begin in August and last 4-6 weeks. He also said that Abivirtinib would be a great drug to combine with CAR-T cancer drugs to prevent cytokine storm which has been a real problem. It has already been shown to be safe and effective in solid and blood cancers. This a BLOCKBUSTER folks.
https://finance.yahoo.com/video/sorrento-gets-fda-approval-covid-140900770.html

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM